Additional Participants Join CLS’s DLT Bilateral Payment Netting Service – More Market …

… a standardized, automated bilateral payment netting calculation service for over 120 currencies operating on a distributed ledger technology (DLT) …

CLS, a market infrastructure delivering settlement, processing and data solutions, today announces that Actinver, BNP Paribas, Citibank and J.P. Morgan are live on CLSNet, a standardized, automated bilateral payment netting calculation service for over 120 currencies operating on a distributed ledger technology (DLT) platform.

There are now nine market participants live on CLSNet, including Bank of America, Bank of China (Hong Kong), Goldman Sachs, Intesa Sanpaolo and Morgan Stanley, with several other market participants due to join over the coming year.

CLSNet standardizes and increases the levels of payment netting in the FX market, enabling improvements to intraday liquidity, greater operational efficiency and increased risk mitigation for non-CLS-settled currencies, many of which are in emerging markets that are growing faster than those in current CLS jurisdictions.

In addition to existing CLS settlement members, CLSNet can be used directly by non-CLS banks and the buy side, enabling a wider group of market participants to benefit from the reduction in operational costs and risk the service delivers.

Alan Marquard, Chief Business Development Officer, CLS, said: “The addition of these latest participants is testament to the value which CLSNet is delivering to the FX market. The service continues to gain flow and participants and is operating efficiently. We will continue to invest in the growth and resilience of the service and have a roadmap of enhancements that will further expand the value proposition to clients.”

Héctor Sánchez, Head of Operations, Actinver added: “CLSNet will enable us to address our wider post-trade processing needs and increase our operational efficiency by optimizing liquidity, enabling real-time awareness of currency and counterparty exposures, and reducing risk.”

Joe Nash, Foreign Exchange and Local Markets Digital COO,BNP Paribas, added: “We are looking forward to seeing significant benefits to BNP Paribas in the form of reduced operational processes and associated risks, as well as support for business growth in the trading of non-core currencies.”

Mike Lawrence, Global CAO Rates & Currencies, Citibank said: “We are delighted to become a participant of the CLSNet service. CLSNet brings high-quality industry standardization to previously fragmented and inefficient bilateral netting models. It will enable broader access to settlement netting as a risk mitigant at an industry level, whilst delivering significant operational efficiencies as the network builds.”

Brian Gallagher, Managing Director, Markets Operations, J.P. Morgan, said, “CLSNet will bring efficiencies in the FX settlement for non-CLS settled transactions and provide other valuable benefits to our FX business.”

Related Posts:

  • No Related Posts

Today Raymond James Financial Inc (NYSE:RJF) Reported Decrease in Shorted Shares

Toronto Dominion Bancorp holds 0% or 74,364 shares. Bridgewater Associates Limited Partnership holds 35,798 shares. Comerica Savings Bank has …

Raymond James Financial, Inc. (NYSE:RJF) Logo

Investors sentiment increased to 0.97 in Q2 2019. Its up 0.03, from 0.94 in 2019Q1. It improved, as 30 investors sold Raymond James Financial, Inc. shares while 140 reduced holdings. 51 funds opened positions while 114 raised stakes. 92.55 million shares or 2.04% less from 94.48 million shares in 2019Q1 were reported.

Qs reported 1,200 shares stake. Regions Corporation invested in 0.02% or 20,472 shares. Quantbot Technology Lp invested in 0.01% or 1,453 shares. Retirement Sys Of Alabama stated it has 0.02% in Raymond James Financial, Inc. (NYSE:RJF). Vanguard Group invested in 13.79 million shares or 0.04% of the stock. Arizona-based Tci Wealth has invested 0% in Raymond James Financial, Inc. (NYSE:RJF). Financial Bank Of New York Mellon holds 0.04% or 1.79 million shares. First Trust Ltd Partnership holds 0.12% in Raymond James Financial, Inc. (NYSE:RJF) or 772,906 shares. Zebra Capital Mgmt Lc holds 0.13% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF) for 3,011 shares. Group One Trading Limited Partnership holds 2,000 shares or 0% of its portfolio. Meeder Asset Inc invested in 102 shares or 0% of the stock. Highland Cap Management Lp has 3,835 shares for 0.02% of their portfolio. Toronto Dominion Bancorp holds 0% or 74,364 shares. Bridgewater Associates Limited Partnership holds 35,798 shares. Comerica Savings Bank has 0.03% invested in Raymond James Financial, Inc. (NYSE:RJF) for 41,070 shares.

The stock of Raymond James Financial Inc (NYSE:RJF) registered a decrease of 15.45% in short interest. RJF’s total short interest was 1.76 million shares in September as published by FINRA. Its down 15.45% from 2.08 million shares, reported previously. With 928,200 shares average volume, it will take short sellers 2 days to cover their RJF’s short positions. The short interest to Raymond James Financial Inc’s float is 1.4%.

The stock increased 0.81% or $0.7 during the last trading session, reaching $87.11. About 998,657 shares traded or 4.85% up from the average. Raymond James Financial, Inc. (NYSE:RJF) has declined 11.35% since September 15, 2018 and is downtrending. It has underperformed by 11.35% the S&P500.

Raymond James Financial, Inc., a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company has market cap of $12.10 billion. The firm operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other divisions. It has a 12.35 P/E ratio. The Private Client Group segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance products to their individual clients; and borrowing and lending of securities to and from other broker-dealers, financial institutions, and other counterparties.

Raymond James Financial, Inc. (NYSE:RJF) Ratings Coverage

Among 2 analysts covering Raymond James Financial (NYSE:RJF), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Raymond James Financial has $94 highest and $9200 lowest target. $93’s average target is 6.76% above currents $87.11 stock price. Raymond James Financial had 7 analyst reports since March 23, 2019 according to SRatingsIntel. The company was maintained on Friday, April 5 by Wells Fargo. The firm has “Neutral” rating given on Monday, April 15 by Citigroup.

More notable recent Raymond James Financial, Inc. (NYSE:RJF) news were published by: Seekingalpha.com which released: “Raymond James Financial: Positioned To Thrive In The Next Crisis – Seeking Alpha” on July 09, 2019, also Seekingalpha.com with their article: “Raymond James July client AUM rises to record $831.1B – Seeking Alpha” published on August 21, 2019, Bizjournals.com published: “Raymond James launches $750M stock buyback – Tampa Bay Business Journal” on August 19, 2019. More interesting news about Raymond James Financial, Inc. (NYSE:RJF) were released by: Seekingalpha.com and their article: “Raymond James Financial Q3 2019 Earnings Preview – Seeking Alpha” published on July 23, 2019 as well as Seekingalpha.com‘s news article titled: “Key Risks Weighing Down Raymond James Financial, Inc. – Seeking Alpha” with publication date: June 19, 2019.

Raymond James Financial, Inc. (NYSE:RJF) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Infosys Limited (NYSE:INFY) Analyst’s Long Term Pick As Shares Moved 24.31% This Year

Infosys Limited (NYSE:INFY) has been recommended as a long term growth stock according to analysts at Beta Research. With their stock price …

Infosys Limited (NYSE:INFY) has been recommended as a long term growth stock according to analysts at Beta Research. With their stock price currently trading around $11.77, the firm has proven a solid track record of growth over the past few years. Investors might consider the stock as a long term growth candidate as the firm has yielded 147.20% earnings per share growth over the past 5 years and 151.30% revenue growth over that same time frame.

Investors studying the fundamentals might be conducting in-depth company research before deciding when to purchase a particular stock. The investor checklist may include studying the scope of a company’s competitive industry advantage, examining company management, and trying to get a general feel if the stock is valued properly. Once the decision is made that the company is a good fit for the portfolio, it may be wise to assess whether or not current conditions and price levels indicate proper levels for share purchase. The timing of purchasing a researched stock obviously comes with some level of trepidation. Investors will only know in the future whether they got in at the right price. A stock that looks very attractive today may not be as attractive in the future. Sometimes the investor will just have to trust their research and instinct when purchasing shares.

Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time. Long-term growth should be considered to be a relative term, due to different styles and goals of investors, but the endgame is the same.

A “buy-and-hold” investor will consider long-term growth as a longer time period then a day trader will. The buy-and-hold strategy looks ahead farther into the future, giving short-term price swings less consideration as long as the fundamentals stay the same. A trader is looking more closely at a weekly, or shorter, time frame and is more interested in immediate price fluctuations.

Just-released reportnames Cannabis Stock of the Year for 2019!Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that isunlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more.Click here to receive your Free Report immediately!

Let’s take a look at how the stock has been performing recently. Over the past twelve months, Infosys Limited (NYSE:INFY)’s stock was 24.31%. Over the last week of the month, it was -0.34%, 11.04% over the last quarter, and 10.00% for the past six months.

Over the past 50 days, Infosys Limited’s stock is -2.57% off of the high and 13.50% removed from the low. Their 52-Week High and Low are as follows: -2.57% (High), 33.72%, (Low).

Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $11.42 on the equity. Analysts have a consensus recommendation of 2.90 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

From time to time, investors may need to decide when to sell a winner. This can be one of the tougher portfolio decisions to make. When a winning stock keeps rising, it can be tough to part with it. Investors may become hesitant to sell because they don’t want to miss out on greater profits in the future. Sometimes this strategy will work, and other times investors may be watching all previous gains evaporate. Being able to sell a winner can provide obvious profits, and it may even be a confidence booster for the average investor. On the flip side, investors may also be faced with the decision of when to sell a loser. Even the most researched trades can go sour. Being able to detach from the trade mentally can end up saving the investor more grief down the line. Holding onto a stock with the hopes of a giant turnaround can be a recipe for portfolio disaster. Being able to cut losses is just as much a part of the process as being able to cash in winners. Learning from mistakes and being able to wipe the slate clean can help the investor be better prepared for future endeavors in the markets.

Related Posts:

  • No Related Posts

DNB Financial (NASDAQ:DNBF) Shares Pass Above 200-Day Moving Average of $41.48

Finally, Vanguard Group Inc. increased its stake in DNB Financial by 6.0% during the second quarter. Vanguard Group Inc. now owns 131,627 shares …

DNB Financial logoDNB Financial Corp (NASDAQ:DNBF)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $41.48 and traded as high as $45.10. DNB Financial shares last traded at $45.10, with a volume of 529 shares traded.

A number of equities analysts recently commented on DNBF shares. Zacks Investment Research downgraded DNB Financial from a “buy” rating to a “hold” rating in a research report on Tuesday, August 6th. ValuEngine downgraded DNB Financial from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st.

The stock has a market cap of $192.94 million, a PE ratio of 17.18 and a beta of 0.88. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 0.46. The stock has a 50-day moving average of $42.67 and a 200 day moving average of $41.51.

DNB Financial (NASDAQ:DNBF) last announced its quarterly earnings data on Tuesday, July 23rd. The financial services provider reported $0.60 EPS for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.03). DNB Financial had a return on equity of 9.89% and a net margin of 20.71%. The company had revenue of $10.86 million for the quarter, compared to analysts’ expectations of $10.80 million. Research analysts forecast that DNB Financial Corp will post 2.68 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 18th. Investors of record on Friday, September 6th will be given a dividend of $0.07 per share. The ex-dividend date is Thursday, September 5th. This represents a $0.28 dividend on an annualized basis and a yield of 0.61%. DNB Financial’s payout ratio is 11.29%.

Institutional investors have recently made changes to their positions in the stock. Chicago Capital Management LLC acquired a new stake in DNB Financial during the second quarter worth $79,000. Castine Capital Management LLC increased its stake in DNB Financial by 29.6% during the first quarter. Castine Capital Management LLC now owns 223,055 shares of the financial services provider’s stock worth $8,425,000 after acquiring an additional 50,986 shares during the last quarter. Baldwin Investment Management LLC acquired a new stake in DNB Financial during the first quarter worth $224,000. O Shaughnessy Asset Management LLC acquired a new stake in DNB Financial during the first quarter worth $95,000. Finally, Vanguard Group Inc. increased its stake in DNB Financial by 6.0% during the second quarter. Vanguard Group Inc. now owns 131,627 shares of the financial services provider’s stock worth $5,853,000 after acquiring an additional 7,445 shares during the last quarter. Hedge funds and other institutional investors own 38.15% of the company’s stock.

About DNB Financial (NASDAQ:DNBF)

DNB Financial Corporation operates as the bank holding company for DNB First, National Association that provides a range of commercial banking products and services to individuals and small to medium sized businesses. The company offers deposit products, including money market, savings, demand, and NOW accounts; and time deposits, as well as certificates of deposit, including IRAs and brokered deposits.

Read More: What are Bollinger Bands?

Receive News & Ratings for DNB Financial Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DNB Financial and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Acadian Asset Management LLC Lowers Position in Illumina, Inc. (NASDAQ:ILMN)

Acadian Asset Management LLC lowered its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 78.9% during the second quarter, according to its …

Illumina logoAcadian Asset Management LLC lowered its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 78.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,147 shares of the life sciences company’s stock after selling 8,016 shares during the quarter. Acadian Asset Management LLC’s holdings in Illumina were worth $790,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Migdal Insurance & Financial Holdings Ltd. raised its holdings in shares of Illumina by 40.7% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,413 shares of the life sciences company’s stock worth $888,000 after acquiring an additional 698 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in shares of Illumina by 24.6% during the 2nd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 24,570 shares of the life sciences company’s stock worth $9,045,000 after purchasing an additional 4,856 shares during the period. Bridges Investment Management Inc. purchased a new position in shares of Illumina during the 2nd quarter worth approximately $218,000. Granite Investment Partners LLC purchased a new position in shares of Illumina during the 2nd quarter worth approximately $6,773,000. Finally, Premier Asset Management LLC boosted its position in shares of Illumina by 1.7% during the 2nd quarter. Premier Asset Management LLC now owns 36,039 shares of the life sciences company’s stock worth $13,267,000 after purchasing an additional 595 shares during the period. 90.92% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts recently weighed in on ILMN shares. UBS Group increased their price objective on shares of Illumina from $350.00 to $355.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. ValuEngine upgraded shares of Illumina from a “hold” rating to a “buy” rating in a report on Thursday. Argus reduced their price objective on shares of Illumina to $340.00 and set a “buy” rating on the stock in a report on Thursday, July 18th. Cowen reduced their price objective on shares of Illumina from $380.00 to $320.00 and set an “outperform” rating on the stock in a report on Friday, July 12th. Finally, Piper Jaffray Companies reduced their price objective on shares of Illumina from $382.00 to $348.00 and set an “overweight” rating on the stock in a report on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have assigned a buy rating to the company. Illumina currently has an average rating of “Buy” and an average target price of $330.92.

Shares of NASDAQ ILMN traded up $3.39 during mid-day trading on Friday, reaching $300.91. The company had a trading volume of 1,261,318 shares, compared to its average volume of 951,429. The company has a current ratio of 6.79, a quick ratio of 6.10 and a debt-to-equity ratio of 0.42. The firm has a 50 day simple moving average of $287.45 and a two-hundred day simple moving average of $313.82. The stock has a market cap of $42.58 billion, a P/E ratio of 52.61, a PEG ratio of 2.70 and a beta of 1.09. Illumina, Inc. has a 52-week low of $263.30 and a 52-week high of $380.76.

Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Monday, July 29th. The life sciences company reported $1.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.32 by $0.03. Illumina had a net margin of 27.56% and a return on equity of 21.73%. The company had revenue of $838.00 million for the quarter, compared to the consensus estimate of $835.12 million. During the same period last year, the firm posted $1.43 EPS. Illumina’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities analysts expect that Illumina, Inc. will post 6.05 EPS for the current year.

In other news, SVP Mostafa Ronaghi sold 10,000 shares of Illumina stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $349.28, for a total value of $3,492,800.00. Following the sale, the senior vice president now owns 65,994 shares of the company’s stock, valued at $23,050,384.32. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Francis A. Desouza sold 3,000 shares of Illumina stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $301.25, for a total transaction of $903,750.00. Following the completion of the sale, the chief executive officer now directly owns 64,200 shares in the company, valued at approximately $19,340,250. The disclosure for this sale can be found here. Insiders have sold a total of 56,198 shares of company stock worth $17,773,470 over the last three months. 0.38% of the stock is currently owned by insiders.

About Illumina

Illumina, Inc provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array.

Featured Story: How to interpret the current ratio

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Illumina and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts